Enhanced plasmonic biosensors with machine learning for ultra-sensitive detection.

Plasmonic biosensors, particularly Surface Plasmon Resonance and Surface-Enhanced Raman Spectroscopy, have gained significant attention for real-time, label-free biochemical detection. However, optimizing these sensors for maximum sensitivity and selectivity remains a challenge due to their complex plasmonic interactions with different biomolecules. This work proposes SERA, an AI driven framework that integrates machine learning algorithms with experimental Surface-Enhanced Raman Spectroscopy (SERS) data for the predictive modeling and optimization of plasmonic sensing performance. Using supervised learning techniques, the ML models are trained on a spectral dataset - SERS-DB obtained from various plasmonic nanostructures. The model predicts key parameters such as resonance shift, intensity variations, and molecular binding efficiency, allowing for rapid optimization of biosensor designs without extensive trial-and-error experimentation. This approach accelerates plasmonic biosensor development and enables real-time adaptive sensing based on live data. The results through evaluation on the SERS-DB database with 420 samples for training and 180 for the testing phase, 6 classes like Thiacloprid, Imidacloprid, Thiamethoxam, Nitenpyram, Tetrahydrofolate, and Dihydrofolate, an accuracy of 92%, precision & recall of 90%, and F1-score of 92% were attained. The SERA model excelled with an overall score of around 0.90 in all 6 classes, proving additional superiority in biosensing applications. Further comparative analysis of the proposed approach with conventional methods underscores the best performance in accuracy with 92%, sensitivity, 1000 nm/RIU, and 95% in optimization efficiency. Overall, this research highlights a scalable and cost-effective strategy for advancing biosensor technology in medical diagnostics, environmental monitoring, and bio photonics.